Table 2 Association of baseline characteristics between patients who deteriorated and those who did not deteriorate (N = 460)
No deterioration | Deteriorated | ||
|---|---|---|---|
Baseline Variables in 1998 | eGFR ≥ 60 ml/min (n = 318) | eGFR < 60 ml/min (n = 142) | p-value |
Age, years | 52.3 ± 7.9 | 60.5 ± 7.9 | <0.001 |
Males (n, %) | 99 (31.1) | 63 (44.7) | 0.005 |
Race, Malay (n, %) | 82 (25.9) | 34 (24.1) | 0.889 |
Race, Chinese (n, %) | 157 (49.5) | 73 (51.8) | |
Race, Indian (n, %) | 75 (23.7) | 33 (23.4) | |
RAAS use (n, %) | 30 (9.4) | 22 (15.6) | 0.057 |
Smoker (n, %) | 16 (5.0) | 14 (9.9) | 0.683 |
Serum uric acid (umol/L) | 301 ± 84 | 325 ± 87 | 0.011 |
HbA1c (%) | 7.4 ± 1.7 | 7.5 ± 1.5 | 0.770 |
Baseline eGFR ( ml/min/1.73 m2) | 93 ± 26 | 74 ± 15 | <0.001 |
Weight, Kg | 70 ± 12 | 68 ±13 | 0.063 |
Systolic BP, mmHg | 144 ± 18 | 146 ± 18 | 0.204 |
Diastolic BP, mmHg | 88 ± 10 | 87 ± 10 | 0.210 |
Achieved BP* control, (n, %) | 55 (17.3) | 15 (10.6) | 0.050 |
Diabetics hypertensive, (n, %) | 89 (28.0) | 58 (41.1) | 0.004 |